BACKGROUND:Diuretic treatment for heart failure may lead to an increased urinary thiamine excretion and in long-term thiamine deficiency, which may further compromise cardiac function. This study evaluated the effect of high dose thiamine supplementation in heart failure patients. METHODS:Nine patients with diuretic treatment for symptomatic chronic heart failure and a left ventricular ejection fraction (LVEF) <40% were randomly assigned to receive thiamine (300 mg/day) or placebo for 28 days. After a wash-out of 6 weeks, the patients crossed-over to a second treatment period. The primary outcome was a change in LVEF. RESULTS:Mean age was 56.7 ± 9.2 years (range 44.9-75.4 years). Baseline LVEF was similar for both treatment groups (29.5% in the thiamine group and 29.5% in the placebo group, P = 0.911). After 28 days of thiamine treatment, the LVEF increased to 32.8% which was significantly (P = 0.024) different from the LVEF in the placebo group (28.8%). This corresponds to a treatment effect for LVEF of 3.9% in absolute terms. CONCLUSIONS: This study suggests that thiamine supplementation has beneficial effects on cardiac function in patients with diuretic drugs for symptomatic chronic heart failure. Subclinical thiamine deficiency is probably an underestimated issue in these outpatients.
RCT Entities:
BACKGROUND: Diuretic treatment for heart failure may lead to an increased urinary thiamine excretion and in long-term thiaminedeficiency, which may further compromise cardiac function. This study evaluated the effect of high dose thiamine supplementation in heart failurepatients. METHODS: Nine patients with diuretic treatment for symptomatic chronic heart failure and a left ventricular ejection fraction (LVEF) <40% were randomly assigned to receive thiamine (300 mg/day) or placebo for 28 days. After a wash-out of 6 weeks, the patients crossed-over to a second treatment period. The primary outcome was a change in LVEF. RESULTS: Mean age was 56.7 ± 9.2 years (range 44.9-75.4 years). Baseline LVEF was similar for both treatment groups (29.5% in the thiamine group and 29.5% in the placebo group, P = 0.911). After 28 days of thiamine treatment, the LVEF increased to 32.8% which was significantly (P = 0.024) different from the LVEF in the placebo group (28.8%). This corresponds to a treatment effect for LVEF of 3.9% in absolute terms. CONCLUSIONS: This study suggests that thiamine supplementation has beneficial effects on cardiac function in patients with diuretic drugs for symptomatic chronic heart failure. Subclinical thiaminedeficiency is probably an underestimated issue in these outpatients.
Authors: Stacy A Hanninen; Pauline B Darling; Michael J Sole; Aiala Barr; Mary E Keith Journal: J Am Coll Cardiol Date: 2006-01-17 Impact factor: 24.094
Authors: Ardan M Saguner; Stefan Dür; Martin Perrig; Uwe Schiemann; Andreas E Stuck; Ulrich Bürgi; Paul Erne; Andreas W Schoenenberger Journal: Am J Hypertens Date: 2010-04-15 Impact factor: 2.689
Authors: Stefano Muzzarelli; Daniel Tobler; Gregor Leibundgut; Ruth Schindler; Peter Buser; Matthias Emil Pfisterer; Hans Peter Brunner-La Rocca Journal: Swiss Med Wkly Date: 2009-08-22 Impact factor: 2.193
Authors: Andreas W Schoenenberger; Dragana Radovanovic; Jean-Christophe Stauffer; Stephan Windecker; Philip Urban; Franz R Eberli; Andreas E Stuck; Felix Gutzwiller; Paul Erne Journal: J Am Geriatr Soc Date: 2008-01-04 Impact factor: 5.562
Authors: Zev M Nakamura; Allison M Deal; Donald L Rosenstein; Laura J Quillen; Stephanie A Chien; William A Wood; Thomas C Shea; Eliza M Park Journal: Contemp Clin Trials Date: 2020-06-30 Impact factor: 2.226
Authors: Frank van Buuren; Klaus Peter Mellwig; Christian Prinz; Britta Körber; Andreas Fründ; Dirk Fritzsche; Lothar Faber; Tanja Kottmann; Nicola Bogunovic; Johannes Dahm; Dieter Horstkotte Journal: Clin Res Cardiol Date: 2013-04-12 Impact factor: 5.460